Ms Charla Megan Perez, | |
200 Ucla Medical Plz Ste B265, Los Angeles, CA 90095-1804 | |
(310) 267-9099 | |
Not Available |
Full Name | Ms Charla Megan Perez |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 200 Ucla Medical Plz Ste B265, Los Angeles, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275122921 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 95015614 (California) | Secondary |
363LA2100X | Nurse Practitioner - Acute Care | 95015614 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Charla Megan Perez, 5767 W Century Blvd Ste 400, Los Angeles, CA 90045-5631 Ph: (310) 301-8732 | Ms Charla Megan Perez, 200 Ucla Medical Plz Ste B265, Los Angeles, CA 90095-1804 Ph: (310) 267-9099 |
News Archive
Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has entered into research agreements with The University of Pittsburgh Medical Center, Brigham and Women's Hospital, the H. Lee Moffitt Cancer Center, Dartmouth's Hitchcock Medical Center and the University of Sherbrooke to develop a microRNA-based diagnostic test to aid the detection of pancreatic cancer from fine-needle aspirate (FNA) biopsies.
The World Health Organization (WHO) Global Strategy on Diet, Physical Activity and Health was today endorsed by Member States at their annual Health Assembly in Geneva. The strategy addresses two of the major risk factors responsible for the heavy and growing burden of noncommunicable diseases (NCDs), which now account for some 60% of global deaths and almost half (47%) of the global burden of disease. NCDs include cardiovascular disease, type 2 diabetes, cancers and obesity-related conditions.
Lumosity announced today it has raised $32.5 million in Series C financing. Lumosity leverages cutting-edge neuroscience to create games and exercises that improve core cognitive abilities and enable users to remember more, think faster and perform better at work and school.
When the only community health care center providing medical and psychosocial care for people living with HIV/AIDS in India's northernmost state of Jammu and Kashmir "closed down six months ago for lack of patients, it was a sure sign that the north Indian state had beaten back dire forecasts," Inter Press Service reports.
› Verified 7 days ago